Table 4 Hormonal dynamics in FHA women with and without PCOM who responded to three months of pulsatile GnRH treatment
FHA patients without PCOM (n = 12) | FHA patients with PCOM (n = 7) | |||||
|---|---|---|---|---|---|---|
Baseline | 3-months follow-up | p | Baseline | 3-months follow-up | p | |
FSH (mIU/mL) | 5.1 (1.6;7.5) | 6.9 (3.7;8.4) | 0.002 | 4.8 (4.0;6.5) | 5.0 (4.2;5.4) | 0.933 |
LH (mIU/mL) | 1.5 (0.3;4.9) | 4.6 (3.8;6.3) | 0.016 | 3.0 (0.6;6.9) | 7.3 (6.6;9.1) | 0.018 |
Estradiol (pg/mL) | 21 (9;36) | 46 (38;55) | 0.005 | 24 (11;41) | 56 (49;66) | 0.028 |
AMH (ng/mL) | 1.69 (1.58;2.20) | 2.02 (1.81;2.49) | 0.002 | 4.9 (3.6;7.4) | 5.2 (3.6;6.3) | 0.237 |